NCT04333771 A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT04324892 Effects of Achieving SDAI Remission on Joint Space Outcomes Progression in Early Rheumatoid Arthritis: an HR-pQCT Study Status UNKNOWN Phase N/A
NCT04321798 Promoting Engagement in Physical Activity in Early Rheumatoid Arthritis: Proof of Concept Study Status COMPLETED Phase NA
NCT04315818 The Relation Between Macrophage Migration Inhibitory Factor (MIF) and 25(OH) Vitamin D3 Serum Levels in Rheumatoid Arthritis Status UNKNOWN Phase N/A
NCT04311567 Effects of Tofacitinib vs Methotrexate on Rheumatoid Arthritis Interstitial Lung Disease Status TERMINATED Phase PHASE4
NCT04309227 Comparison of Training Load With/Out Blood Flow Restriction Training in Rheumatoid Populations Status TERMINATED Phase NA
NCT04306939 Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study Status SUSPENDED Phase N/A
NCT04300465 MySlainte: Testing the Effect of Involving Partners in a CVD Prevention Community Lifestyle Program Status UNKNOWN Phase NA
NCT04297475 The Clinical Feasibilityof a Multi-modal Photoacoustic/Ultrasonic Imaging System in Rheumatoid Arthritis Status UNKNOWN Phase N/A
NCT04292067 Characterisation of Intestinal Microbiota of Patients With Spondyloarthritis or Rheumatoid Arthritis Status RECRUITING Phase N/A
NCT04286789 Randomized, Double-blind, Vehicle Controlled, Repeat Dose Comparative Study in RA Patients Managed With DMARDs Status COMPLETED Phase PHASE1
NCT04284735 Lysophosphatidic Acid / Autotaxin Axis in Rheumatoid Lung Disease Status UNKNOWN Phase NA
NCT04281602 Biomarkers in Rheumatoid Arthritis Treated With Anti-interleukin-6 Therapy Status UNKNOWN Phase N/A
NCT04279691 Prolactin Hormone in Rheumatoid Arthritis Patients With Periodontitis Status UNKNOWN Phase N/A
NCT04269993 Impact of Cannabis on Pain and Inflammation Among Patients With Rheumatoid or Psoriatic Arthritis Status TERMINATED Phase PHASE2
NCT04268771 A Phase III Transition Study of DRL Rituximab to Reference Medicinal Products Status COMPLETED Phase PHASE3